Uveal melanoma in young patients

Archives of Ophthalmology

Volumn 118, Issue 7, 2000, Pages 918-923

  Singh, Arun D ^a   Shields, Carol L ^a   Shields, Jerry A ^a   Sato, Takami ^b  

^a WILLS EYE HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTOSIS; PRIORITY JOURNAL; UVEA MELANOMA; VISUAL ACUITY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; PEDIGREE; PENNSYLVANIA; RETROSPECTIVE STUDIES; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 0033926659     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cury D, Lucic H, Irvine AR Jr. Prepubertal intraocular malignant melanoma. Am J Ophthalmol. 1959;47:202-206.
2. Ellsworth RM. Juvenile melanoma of the uvea. Trans Am Acad Ophthalmol Otolaryngol. 1960;64:148-149.
3. Apt L. Uveal melanomas in children and adolescents. Int Ophthalmol Clin. 1962; 2:403-410.
4. Verdaguer J Jr. Prepubertal and pubertal melanomas in ophthalmology. Am J Ophthalmol. 1965;60:1002-1011.
5. Reese AB. Congenital melanomas. Am J Ophthalmol. 1974;77:798-808.
6. Leonard BC, Shields JA, McDonald PR. Malignant melanomas of the uveal tract in children and young adults. Can J Ophthalmol. 1975;10:441-449.
7. Barr CC, McLean IW, Zimmerman LE. Uveal melanoma in children and adolescents. Arch Ophthalmol. 1981;99:2133-2136.
8. Shields CL, Shields JA, Milite J, De Potter P, Sabbagh R, Menduke H. Uveal melanoma in teenagers and children. Ophthalmology. 1991;98:1662-1666.
9. Greer CH. Congenital melanoma of the anterior uvea. Arch Ophthalmol. 1966; 76:77-78.
10. Broadway D, Lang S, Harper J, et al. Congenital malignant melanoma of the eye. Cancer. 1991;67:2642-2652.
11. Shields JA, Shields CL. Intraocular Tumors: A Text and Atlas. Philadelphia, Pa: WB Saunders Co; 1992:171-205.
12. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239-251.
13. Singh AD, Wang MX, Donoso LA, Shields CL, De Potter P, Shields JA. Genetic aspects of uveal melanoma: a brief review. Semin Oncol. 1996;23:768-772.
14. Singh AD, Shields CL, De Potter P, et al. Familial uveal melanoma: clinical observations on 56 patients. Arch Ophthalmol. 1996;114:392-399.
15. Young LHY, Egan KM, Walsh SM, Gragoudas ES. Familial uveal melanoma. Am J Ophthalmol. 1994;117:516-520.
16. Canning CR, Hungerford J. Familial uveal melanoma. Br J Ophthalmol. 1988;72: 241-243.
17. Jay M, McCartney ACE. Familial malignant melanoma of the uvea and p53: a Victorian detective story. Surv Ophthalmol. 1993;37:457-462.
18. Ponder BAJ. Inherited cancer syndromes. In: Carney D, Sikora K, eds. Genes and Cancer. New York, NY: John Wiley & Sons Ltd; 1990:99-106.
19. Singh AD, Shields CL, Shields JA, De Potter P. Bilateral primary uveal melanoma: bad luck or bad genes? Ophthalmology. 1996;103:256-262.
20. Singh AD, De Potter P, Fijal BA, Shields CL, Shields JA, Elston RC. Lifetime prevalence of uveal melanoma in caucasian patients with oculo(dermal) melanocytosis. Ophthalmology. 1998;105:195-198.
21. Singh AD, Shields CL, Shields JA, Eagle RC Jr, De Potter P. Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome. Ophthalmic Genet. 1995;16:53-61.
22. Gonder JR, Shields JA, Albert DM, Augsburger JJ, Lavin PT. Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology. 1982;89:953-960.
23. Lee ET. Statistical Methods for Survival Data Analysis. 2nd ed. New York, NY: John Wiley & Sons Inc; 1992:66-78.
24. Consensus Statement. Diagnosis and treatment of early melanoma: NIH Consensus Development Conference, January 27-29, 1992. JAMA. 1992;268 1314-1319.
25. Ohta M, Nagai H, Shimizu M, et al. Rarity of somatic and germline mutations of the cyclin dependent kinase-4 inhibitor gene in melanoma. Cancer Res. 1994; 84:5269-5272.
26. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma, II: a meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992;110:245-250.
27. Kroll S, Char DH, Quivey J, Castro J. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology. 1998;105:2035-2045.
28. Greven CM, Stanton C, Yeatts RP, Shields CL. Diffuse iris melanoma in a young patient. Arch Ophthalmol. 1997;115:682-683.
29. Gunduz K, Shields JA, Shields CL, Eagle RC Jr. Choroidal melanoma in a 14-year-old patient with oculodermal melanocytosis. Arch Ophthalmol. 1998;116: 1112-1114.
30. Singh AD, Shields JA, Eagle RC, Shields CL, Marmor M, De Potter P. Iris melanoma in a ten-year-old boy with familial atypical mole melanoma (FAM-M) syndrome. Ophthalmic Genet. 1994;15:145-149.
31. Abramson DH, Rodriguez Sains RS, Rubman R. BK mole syndrome: cutaneous and ocular malignant melanoma. Arch Ophthalmol. 1980;98:1397-1399.
32. Jensen OA. Malignant melanoma in an infant with dysplastic nevus syndrome. Acta Ophthalmol. 1987;65:91-100.
33. Bellet RB, Shields JA, Soll D, Bernardino EA. Primary choroidal and cutaneous melanomas occurring in a patient with the BK mole syndrome phenotype. Am J Ophthalmol. 1980;89:567-570.
34. Taylor MR, Guerry D, Bondi EE, et al. Lack of association between intraocular melanoma and cutaneous dysplastic nevi. Am J Ophthalmol. 1984;98:478-482.
35. Ruiz-Maldonado R, Orozco-Covarrubias MdIL. Malignant melanoma in children: a review. Arch Dermatol. 1997;133:363-371.
36. Gilbert CM, Baba FE, Schachat AP, Grossniklaus H, Green RW. Non simultaneous primary choroidal and cutaneous melanomas. Ophthalmology. 1987;94: 1169-1172.
37. Pomeranz GA, Bunt AH, Kalina RE. Multifocal choroidal melanoma in ocular melanocytosis. Ophthalmology. 1982;89:950-952.
38. Seregard S, Ladenwell G, Kock E. Multiple melanocytic tumors in a case of ocular melanocytosis. Acta Ophthalmol. 1993;71:562-565.
39. Specht CS, Smith TW. Uveal malignant melanoma and von Recklinghausen's neurofibromatosis. Cancer. 1988;62:812-817.
40. Haluska FG, Hodi FS. Molecular genetics of familial cutaneous melanoma. J Clin Oncol. 1998;16:670-682.
41. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet. 1994;8:15-21.
42. Gruis NA, van der Velden PA, Sandkuijl LA, et al. Homozygotes for CDKN2 (p16) germline mutations in Dutch familial melanoma kindreds. Nat Genet. 1995;10: 351-353.
43. Kamb A, Gruis NA, Weaver Feldhaus J, et al. A cell regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-440.
44. Nobori T, Miura K, Wu DJ, et al. Deletion of the cyclin dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
45. Singh AD, Nagai H, Croce CM, et al. Familial uveal melanoma: absence of germline mutations involving the cyclin dependent kinase-4 inhibitor (p16) gene. Ophthalmic Genet. 1996;17:39-40.